Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Retained Earnings (2018 - 2025)

TransMedics (TMDX) has 8 years of Retained Earnings data on record, last reported at $124000.0 in Q4 2025.

  • For Q4 2025, Retained Earnings rose 134.07% year-over-year to $124000.0; the TTM value through Dec 2025 reached $124000.0, up 134.07%, while the annual FY2025 figure was $124000.0, 134.07% up from the prior year.
  • Retained Earnings reached $124000.0 in Q4 2025 per TMDX's latest filing, up from -$383.3 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $124000.0 in Q4 2025 and bottomed at -$507.7 million in Q3 2023.
  • Average Retained Earnings over 5 years is -$272.1 million, with a median of -$412.2 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: plummeted 2686150.0% in 2021, then surged 134.07% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$442.4 million in 2021, then soared by 99.95% to -$225000.0 in 2022, then grew by 11.56% to -$199000.0 in 2023, then crashed by 82.91% to -$364000.0 in 2024, then soared by 134.07% to $124000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were $124000.0 in Q4 2025, -$383.3 million in Q3 2025, and -$407.7 million in Q2 2025.